Literature DB >> 30133149

p53 tumor suppressor and iron homeostasis.

Jin Zhang1, Xinbin Chen1.   

Abstract

Iron is an essential nutrient for all living organisms and plays a vital role in many fundamental biochemical processes, such as oxygen transport, energy metabolism, and DNA synthesis. Due to its capability to produce free radicals, iron has deleterious effects and thus, its level needs to be tightly controlled in the body. Deregulation of iron metabolism is known to cause diseases, including anemia by iron deficiency and hereditary hemochromatosis by iron overload. Interestingly, dysregulated iron metabolism occurs frequently in tumor cells and contributes to tumorigenesis. In this review, we will discuss the role of p53 tumor suppressor in iron homeostasis.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990FDXRzzm321990; IRP1/2; iron homeostasis; mitochondrial iron homeostasis; p53; tumor suppression

Mesh:

Substances:

Year:  2018        PMID: 30133149      PMCID: PMC6379103          DOI: 10.1111/febs.14638

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  112 in total

1.  Hepcidin, anaemia, and prostate cancer.

Authors:  Toshihiko Tanno; Antoinette Rabel; Michael Alleyne; Y Terry Lee; William L Dahut; James L Gulley; Jeffery L Miller
Journal:  BJU Int       Date:  2011-02       Impact factor: 5.588

Review 2.  Sideroblastic anemia: diagnosis and management.

Authors:  Sylvia S Bottomley; Mark D Fleming
Journal:  Hematol Oncol Clin North Am       Date:  2014-06-02       Impact factor: 3.722

3.  Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.

Authors:  Takahiro Yamasaki; Issei Saeki; Isao Sakaida
Journal:  Hepatol Int       Date:  2014-01-29       Impact factor: 6.047

4.  Deleterious mutation in FDX1L gene is associated with a novel mitochondrial muscle myopathy.

Authors:  Ronen Spiegel; Ann Saada; Jonatan Halvardson; Devorah Soiferman; Avraham Shaag; Simon Edvardson; Yoseph Horovitz; Morad Khayat; Stavit A Shalev; Lars Feuk; Orly Elpeleg
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

5.  Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect.

Authors:  Angelica Olsson; Lisbet Lind; Lars-Eric Thornell; Monica Holmberg
Journal:  Hum Mol Genet       Date:  2008-02-23       Impact factor: 6.150

6.  Insights on regulation and function of the iron regulatory protein 1 (IRP1).

Authors:  Jian Wang; Guohua Chen; Carine Filebeen; Kostas Pantopoulos
Journal:  Hemoglobin       Date:  2008       Impact factor: 0.849

7.  Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).

Authors:  Carole Peyssonnaux; Annelies S Zinkernagel; Reto A Schuepbach; Erinn Rankin; Sophie Vaulont; Volker H Haase; Victor Nizet; Randall S Johnson
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

8.  The p53-dependent expression of frataxin controls 5-aminolevulinic acid-induced accumulation of protoporphyrin IX and photo-damage in cancerous cells.

Authors:  Mari Sawamoto; Takafumi Imai; Mana Umeda; Koji Fukuda; Takao Kataoka; Shigeru Taketani
Journal:  Photochem Photobiol       Date:  2012-09-13       Impact factor: 3.421

Review 9.  Hepcidin - A novel biomarker with changing trends.

Authors:  Arunava Kali; Marie Victor Pravin Charles; Rathan Shetty Kolkebail Seetharam
Journal:  Pharmacogn Rev       Date:  2015 Jan-Jun

10.  Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy.

Authors:  Yanyan Peng; Deepali N Shinde; C Alexander Valencia; Jun-Song Mo; Jill Rosenfeld; Megan Truitt Cho; Adam Chamberlin; Zhuo Li; Jie Liu; Baoheng Gui; Rachel Brockhage; Alice Basinger; Brenda Alvarez-Leon; Peter Heydemann; Pilar L Magoulas; Andrea M Lewis; Fernando Scaglia; Solange Gril; Shuk Ching Chong; Matthew Bower; Kristin G Monaghan; Rebecca Willaert; Maria-Renee Plona; Rich Dineen; Francisca Milan; George Hoganson; Zoe Powis; Katherine L Helbig; Jennifer Keller-Ramey; Belinda Harris; Laura C Anderson; Torrian Green; Stacey J Sukoff Rizzo; Julie Kaylor; Jiani Chen; Min-Xin Guan; Elizabeth Sellars; Steven P Sparagana; James B Gibson; Laura G Reinholdt; Sha Tang; Taosheng Huang
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

View more
  14 in total

1.  Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression.

Authors:  Yanhong Zhang; Xiuli Feng; Jin Zhang; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2020-04-10       Impact factor: 5.852

2.  FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression.

Authors:  Jin Zhang; Xiangmudong Kong; Yanhong Zhang; Wenqiang Sun; Jian Wang; Mingyi Chen; Xinbin Chen
Journal:  J Pathol       Date:  2020-05-18       Impact factor: 7.996

3.  The complexity of p53-mediated metabolic regulation in tumor suppression.

Authors:  Yanqing Liu; Wei Gu
Journal:  Semin Cancer Biol       Date:  2021-03-27       Impact factor: 17.012

Review 4.  Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis.

Authors:  Lian-Jiu Su; Jia-Hao Zhang; Hernando Gomez; Raghavan Murugan; Xing Hong; Dongxue Xu; Fan Jiang; Zhi-Yong Peng
Journal:  Oxid Med Cell Longev       Date:  2019-10-13       Impact factor: 6.543

Review 5.  Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer.

Authors:  Matthieu Lacroix; Romain Riscal; Giuseppe Arena; Laetitia Karine Linares; Laurent Le Cam
Journal:  Mol Metab       Date:  2019-10-18       Impact factor: 7.422

6.  Rhinoceros Serum microRNAs: Identification, Characterization, and Evaluation of Potential Iron Overload Biomarkers.

Authors:  Jessye Wojtusik; Erin Curry; Terri L Roth
Journal:  Front Vet Sci       Date:  2021-12-16

7.  Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer.

Authors:  Amjad Ali; Jasmin Shafarin; Hema Unnikannan; Nour Al-Jabi; Rola Abu Jabal; Khuloud Bajbouj; Jibran Sualeh Muhammad; Mawieh Hamad
Journal:  Int J Biol Sci       Date:  2021-10-25       Impact factor: 6.580

8.  Iron overload during the treatment of acute leukemia: pretransplant transfusion experience.

Authors:  Osman Yokus; Celalettin Herek; Tahir Alper Cinli; Hasan Goze; Istemi Serin
Journal:  Int J Hematol Oncol       Date:  2021-11-12

9.  Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis.

Authors:  Yingbin Xie; Yanli Tan; Chao Yang; Xuehao Zhang; Can Xu; Xiaoxia Qiao; Jianglong Xu; Shaohui Tian; Chuan Fang; Chunsheng Kang
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

10.  Ferroptosis in a sarcopenia model of senescence accelerated mouse prone 8 (SAMP8).

Authors:  Yan Huang; Beiling Wu; Dingzhu Shen; Jiulin Chen; Zhihua Yu; Chuan Chen
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.